Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMA
3276
ImageneBio Inc
IMA
$64.2M
| $63.2K | ﹤0.01% |
3,218
| – | – |
|
3277
Intellicheck
IDN
$74.7M
| $61K | ﹤0.01% |
21,785
+3,471
| +19% | +$8.74K |
|
3278
iBio
IBIO
$67.6M
| $59.2K | ﹤0.01% |
24,150
+79
| +0.3% | +$203 |
|
|
LITS
3279
Lite Strategy Inc
LITS
$33.5M
| $57.6K | ﹤0.01% |
23,427
| – | – |
|
3280
Butterfly Network
BFLY
$1.85B
| $57.3K | ﹤0.01% |
+18,247
| New | +$47.5K |
|
3281
Babcock & Wilcox
BW
$1.3B
| $57K | ﹤0.01% |
+34,739
| New | +$73.5K |
|
|
ASRT
3282
DELISTED
Assertio
ASRT
| $56K | ﹤0.01% |
4,287
| – | – |
|
3283
Aprea Therapeutics
APRE
$7.52M
| $56K | ﹤0.01% |
17,064
| – | – |
|
3284
CareCloud
CCLD
$98.2M
| $55.3K | ﹤0.01% |
15,096
+3,641
| +32% | +$10.8K |
|
3285
BioAtla
BCAB
$5.71M
| $52.6K | ﹤0.01% |
1,779
-1,725
| -49% | -$145K |
|
|
VISL
3286
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $52.5K | ﹤0.01% |
13,707
-1,014
| -7% | -$5.17K |
|
3287
Aterian
ATER
$4.23M
| $52.3K | ﹤0.01% |
21,778
| – | – |
|
|
GORV
3288
DELISTED
Lazydays
GORV
| $52.3K | ﹤0.01% |
1,827
-284
| -13% | -$9.18K |
|
3289
Sono-Tek
SOTK
$79.4M
| $51.1K | ﹤0.01% |
12,737
-1,792
| -12% | -$7.92K |
|
3290
DNA X Inc
SONM
$4.61M
| $50.9K | ﹤0.01% |
895
| – | – |
|
|
VXRT
3291
DELISTED
Vaxart
VXRT
| $50K | ﹤0.01% |
75,491
| – | – |
|
|
NBP
3292
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $49.6K | ﹤0.01% |
58,358
| – | – |
|
3293
Marker Therapeutics
MRKR
$20M
| $49.4K | ﹤0.01% |
15,900
-4,378
| -22% | -$15.5K |
|
|
NVNO
3294
enVVeno Medical
NVNO
$6.76M
| $49K | ﹤0.01% |
464
-484
| -51% | -$54.1K |
|
3295
Soluna Holdings
SLNH
$192M
| $48.4K | ﹤0.01% |
23,041
+9,264
| +67% | +$30.7K |
|
3296
Sypris Solutions
SYPR
$43M
| $48.2K | ﹤0.01% |
27,095
| – | – |
|
3297
Lexicon Pharmaceuticals
LXRX
$1.01B
| $48K | ﹤0.01% |
64,966
-11,120
| -15% | -$13.4K |
|
3298
OPAL Fuels
OPAL
$67.7M
| $47.9K | ﹤0.01% |
14,126
| – | – |
|
3299
AlTi Global
ALTI
$404M
| $44.4K | ﹤0.01% |
+10,076
| New | +$42.7K |
|
3300
Actinium Pharmaceuticals
ATNM
$26.7M
| $44K | ﹤0.01% |
34,923
-16,361
| -32% | -$25.4K |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.